Roflumilast is not suitable for all COPD patients. Patients with moderate or greater hepatic impairment and patients with depression are groups r...
Roflumilast is a phosphodiesterase-4 (PDE4) inhibitor used to reduce the risk of acute exacerbations in patients with chronic obstructive pulmona...
Olmesartan medoxomil lowers blood pressure smoothly, but during treatment attention should be paid to hypotension, hyperkalemia, changes in renal...
Olmetec is not suitable for all hypertensive patients. The following three groups of people should be prohibited or avoided from using it, and ...
Olmesartan medoxomil has good overall tolerability, but some patients may experience dizziness, fatigue, or back pain. Most symptoms are mild a...
Olmetec is an angiotensin II receptor antagonist used to treat hypertension. Proper use is the key to ensuring efficacy and safety. 1、 Usage...
During the treatment of erlotinib, it is important to monitor rash, diarrhea, interstitial lung disease, and liver toxicity. Early identificati...
Erlotinib should be used with special caution in patients with severe liver and kidney dysfunction, pregnancy, and lactation, and should be avo...
Common skin adverse reactions of erlotinib include acne like rash, dry skin, and paronychia. Scientific care can alleviate symptoms and maintai...
Erlotinib should be taken on an empty stomach to ensure stable absorption. Omission and dosage adjustment should follow the specifications. The...